Verrica Pharmaceuticals Inc.

VRCA · Nasdaq · SIC 2834: Pharmaceutical Preparations
159
SEC Filings

Business Summary

PART I Overview We are a therapeutics company developing and commercializing medications for the treatment of dermatologic diseases, including skin cancers. Currently, our commercial product and portfolio of product candidates are clinician administered therapies in areas of high unmet need. This product portfolio consists of one product with an approved indication for molluscum contagiosum, or molluscum, with the potential for several follow-on indications, as well as additional pipeline produc...

Next Earnings

Q2 FY2026 — expected 2026-08-21

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionVRCAdiscussed_in_filing Cybersecurity
topic_mentionVRCAdiscussed_in_filing Trusted Computing
topic_mentionVRCAdiscussed_in_filing Blockchain & Crypto
topic_mentionVRCAdiscussed_in_filing Regulation
topic_mentionVRCAdiscussed_in_filing Automotive
topic_mentionVRCAdiscussed_in_filing Healthcare & Bio
topic_mentionVRCAdiscussed_in_filing Cybersecurity
topic_mentionVRCAdiscussed_in_filing Trusted Computing
topic_mentionVRCAdiscussed_in_filing Blockchain & Crypto
topic_mentionVRCAdiscussed_in_filing Regulation
topic_mentionVRCAdiscussed_in_filing Automotive
topic_mentionVRCAdiscussed_in_filing Healthcare & Bio
topic_mentionVRCAdiscussed_in_filing Cybersecurity
topic_mentionVRCAdiscussed_in_filing Trusted Computing
topic_mentionVRCAdiscussed_in_filing Blockchain & Crypto
topic_mentionVRCAdiscussed_in_filing Regulation
topic_mentionVRCAdiscussed_in_filing Automotive
topic_mentionVRCAdiscussed_in_filing Healthcare & Bio
topic_mentionVRCAdiscussed_in_filing Cybersecurity
topic_mentionVRCAdiscussed_in_filing Trusted Computing

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-112025-12-310001660334-26-000008EDGAR82K words
2025-03-112024-12-310000950170-25-037172EDGAR—
2024-02-292023-12-310000950170-24-022659EDGAR—
2023-03-062022-12-310000950170-23-006118EDGAR—
2022-03-022021-12-310000950170-22-002685EDGAR—
2021-03-172020-12-310001564590-21-013876EDGAR—
2020-03-132019-12-310001564590-20-010832EDGAR—
2019-03-072018-12-310001564590-19-006800EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-142025-09-300001660334-25-000006EDGAR22K words
2025-08-122025-06-300000950170-25-107358EDGAR—
2025-05-132025-03-310000950170-25-070452EDGAR—
2024-11-052024-09-300000950170-24-120982EDGAR—
2024-08-142024-06-300000950170-24-096669EDGAR—
2024-05-132024-03-310000950170-24-058208EDGAR—
2023-11-092023-09-300000950170-23-061543EDGAR—
2023-08-082023-06-300000950170-23-039375EDGAR—
2023-05-092023-03-310000950170-23-019169EDGAR—
2022-11-072022-09-300000950170-22-022647EDGAR—
2022-08-112022-06-300000950170-22-016660EDGAR—
2022-05-092022-03-310000950170-22-008242EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-110001193125-26-101126EDGAR6K words
2025-12-300001193125-25-335824EDGAR—
2025-11-240001193125-25-292155EDGAR—
2025-11-140001193125-25-283078EDGAR—
2025-08-120001193125-25-178954EDGAR—
2025-07-300001193125-25-169309EDGAR—
2025-07-230001193125-25-162939EDGAR—
2025-07-010001193125-25-153471EDGAR—
2025-06-120001193125-25-139959EDGAR—
2025-06-050001193125-25-135949EDGAR—

159 total filings indexed. 129 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001660334
TickerVRCA
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 09e076390775bbea736f431e21cb858c071b4f402cd476c0beed50025ed4c987
parent: 3740ba550cf4f4cba6d53fb075167c556935335d14a69e2c07e35bc937f946b8
content hash: aaf22dd876b05eff862fd56414c8a7b110f51eb712fca0a9fb3a674728266727
signed: 2026-04-13T04:48:07.824Z
sources: 20 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf